Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 15, 2022

SELL
$9.95 - $12.27 $1,184 - $1,460
-119 Closed
0 $0
Q1 2022

Apr 21, 2022

SELL
$9.81 - $15.4 $1,981 - $3,110
-202 Reduced 62.93%
119 $1,000
Q4 2021

Jan 20, 2022

BUY
$12.09 - $14.68 $12 - $14
1 Added 0.31%
321 $4,000
Q3 2021

Oct 28, 2021

BUY
$13.25 - $15.13 $4,240 - $4,841
320 New
320 $4,000
Q2 2021

Jul 27, 2021

SELL
$12.97 - $16.15 $4,241 - $5,281
-327 Closed
0 $0
Q1 2021

Apr 22, 2021

SELL
$13.59 - $18.54 $67 - $92
-5 Reduced 1.51%
327 $5,000
Q4 2020

Feb 05, 2021

BUY
$14.3 - $18.74 $4,747 - $6,221
332 New
332 $6,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.6B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Destiny Wealth Partners, LLC Portfolio

Follow Destiny Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Destiny Wealth Partners, LLC with notifications on news.